Lupus Science & Medicine®
is a global, peer-reviewed, open access lupus journal from LFA, publishing papers on all aspects of lupus and related diseases.
Impact factor: 3.9
Citescore: 5.0
All metrics >>
Publish in LSM
Lupus Science & Medicine considers submissions of a range of article types, including original research, brief communications, study protocols and meeting reports.
Information is also provided on editorial policies and open access.
This is an open access journal that levies an Article Publishing Charge (APC). Discounts and waivers are available; details are provided in the Author Information section.
All manuscripts should be submitted online.
Published articles are discoverable via PubMed, Web of Science, Scopus and Google Scholar.
Latest Articles
Clinical trials and drug discovery:
Efficacy and safety of telitacicept in patients with systemic lupus erythematosus: a multicentre, retrospective, real-world study25 November 2023
Cutaneous lupus:
Genotype-guided new approach for dose optimisation of hydroxychloroquine administration in Chinese patients with SLE23 November 2023
Animal models:
In vivo ameliorative effects of vitamin E against hydralazine-induced lupus21 November 2023
Lupus Academy 2023
Lupus Science & Medicine is delighted to be the official journal of the 12th Annual Meeting of the Lupus Academy, which was held 8th-10th September 2023 in Barcelona, Spain as a hybrid meeting.
Read the abstracts from the conference which are published online as a supplement to Lupus Science & Medicine.
LSM Podcasts
Most Read Articles
Immunology and inflammation:
Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus11 January 2023
Immunology and inflammation:
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks5 May 2023
Featured Video
Lupus Science & Medicine
The official journal of the Lupus Foundation of America and the premier open-access journal dedicated to lupus research.
Find out more